Santander

Santander 39011

1 studies enrolling now · 2 studies all time

What they study most

Cirrhosis, Hypertension, Pulmonary, Lung Diseases, Interstitial, Non-alcoholic Steatohepatitis, Portal Hypertension

Studies at this site

• Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease — Recruiting now
• Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension — Completed